Cargando…
Should we rely on trials with disease- rather than patient-oriented endpoints?
Autores principales: | de Grooth, Harm-Jan, Parienti, Jean-Jacques, Oudemans-van Straaten, Heleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924659/ https://www.ncbi.nlm.nih.gov/pubmed/28608246 http://dx.doi.org/10.1007/s00134-017-4859-0 |
Ejemplares similares
-
Heterogeneity between studies can be explained more reliably with individual patient data
por: de Grooth, Harm-Jan, et al.
Publicado: (2023) -
Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D
por: Amrein, Karin, et al.
Publicado: (2018) -
Twenty articles that critical care clinicians should read about COVID-19
por: Tsang, Jennifer L. Y., et al.
Publicado: (2021) -
Ten things we learned about COVID-19
por: Cecconi, Maurizio, et al.
Publicado: (2020) -
Airway closure, more harmful than atelectasis in intensive care?
por: Hedenstierna, Göran, et al.
Publicado: (2020)